Flemming M Christensen

Title: Flemming M Christensen: Innovator in Enzyme Technology

Introduction

Flemming M Christensen is a notable inventor based in Rungsted Kyst, Denmark. He has made significant contributions to the field of enzyme technology, holding a total of 5 patents. His work primarily focuses on the development of rhamnogalacturonases and other enzymes derived from specific strains of fungi.

Latest Patents

Christensen's latest patents include innovations related to rhamnogalacturonase, which is derived from a strain of Aspergillus japonicus. This enzyme exhibits a pH-optimum between 6.5 and 7.0 and retains at least 80% of its maximal activity throughout a pH range of 5.5-12. Additionally, it has a temperature optimum of about 40°C and maintains at least 80% of its maximal activity within the temperature range of 20-60°C. Another patent involves rhamnogalacturonases derived from Aspergillus aculeatus, which has a pH-optimum of about 5.0 and similar activity retention characteristics.

Career Highlights

Flemming M Christensen is associated with Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk has allowed him to explore and innovate in the field of enzyme technology, contributing to advancements that have practical applications in various industries.

Collaborations

Throughout his career, Christensen has collaborated with notable colleagues, including Henrik Dalbo Slashedge and Kurt Dorreich. These collaborations have fostered a productive environment for research and development in enzyme technology.

Conclusion

Flemming M Christensen's contributions to enzyme technology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to impact various applications, showcasing the importance of innovation in biotechnology.